CTOs on the Move

Inversago Pharma

www.inversago.com

 
A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome, diabetes, obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.inversago.com
  • 1 Place Ville-Marie Suite 1670
    Montreal, QC CAN H3B 2B6
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Inversago Pharma raised $35M on 09/08/2020

Similar Companies

Kyowa Kirin

Kyowa Kirin Co., Ltd.

HealthCore

HealthCore is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

major pharmaceuticals

major pharmaceuticals is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tjoapack

Tjoapack is a contract packaging organisation which specialises in developing innovative primary & secondary packaging solutions for the pharma supply chain.

Central Ohio Urology Group